REGULAR CONTENT
Final ID
409
Type
Original Scientific Research-Poster Only
Authors
G Jeon1, J Lee2, S Lee3
Institutions
1CHA University Bundang Medical Center, SEONGNAM, GyeongGi-Do, 2CHA Bundang Medical Center, Seongnam, Gyeonggi-do, 3CHA Bundang Medical Center, Seong-Nam Si, Gyeonggi-do
Purpose
To evaluate the efficacy and safety of uterine artery embolization (UAE) for retained product of conception (RPOC) with marked vascularity
Materials & Methods
Among 416 patients who were diagnosed with RPOC from Jan 2006 to Dec 2015, 14 patients (mean age; 32.2 years, range; 26-45) who underwent UAE were included in this study. All patients presented vaginal bleeding and Doppler study showed markedly increased vascularity. Embolization was performed as a primary treatment to control bleeding in 12 patients and two patients that were preoperative. Previous events were dilatation and curettage (D&C) for artificial (n=11) or incomplete abortion (n=2) and normal spontaneous vaginal delivery (n=1). Mean clinical and imaging follow-up period was 184.1 days (range, 34-699 days) and 42.2 days (range, 2-176 days), respectively. Technical and clinical success rate, angiographic and sonographic findings, and complication were evaluated.
Results
Technical success was achieved in 12 of 14 patients (85.7%) with 2 cases of incomplete embolization due to failed selection of ovarian artery (n=1) and high flow arteriovenous fistula (n=1). Clinical success rate for primary treatment of RPOC was 91.7% (11/12). Successful 11 cases didn't require additional treatment, but 1 patient who persisted mild vaginal bleeding after incomplete embolization underwent D&C. Two patients, who underwent pre-operative embolization, ceased vaginal bleeding after embolization, followed by D&C without bleeding complication. Bilateral UAE was performed in all patients, and extra-uterine feeder was found in 2 cases; ovarian artery and round ligament artery. All patients showed hypervascularity on angiography, and 13 of 14 patients showed dilated early draining vein. Pre-procedure color Doppler study showed echogenic mass with marked vascularity in all patients. Follow-up US (n=9) revealed decreased mass size (mean size; 4.6 cm to 2.3 cm, p < .01) and vascularity, there was no procedure related major complication.
Conclusions
UAE is safe and effective modality as a primary treatment of RPOC with marked vascularity.
Final ID
409
Type
Original Scientific Research-Poster Only
Authors
G Jeon1, J Lee2, S Lee3
Institutions
1CHA University Bundang Medical Center, SEONGNAM, GyeongGi-Do, 2CHA Bundang Medical Center, Seongnam, Gyeonggi-do, 3CHA Bundang Medical Center, Seong-Nam Si, Gyeonggi-do
Purpose
To evaluate the efficacy and safety of uterine artery embolization (UAE) for retained product of conception (RPOC) with marked vascularity
Materials & Methods
Among 416 patients who were diagnosed with RPOC from Jan 2006 to Dec 2015, 14 patients (mean age; 32.2 years, range; 26-45) who underwent UAE were included in this study. All patients presented vaginal bleeding and Doppler study showed markedly increased vascularity. Embolization was performed as a primary treatment to control bleeding in 12 patients and two patients that were preoperative. Previous events were dilatation and curettage (D&C) for artificial (n=11) or incomplete abortion (n=2) and normal spontaneous vaginal delivery (n=1). Mean clinical and imaging follow-up period was 184.1 days (range, 34-699 days) and 42.2 days (range, 2-176 days), respectively. Technical and clinical success rate, angiographic and sonographic findings, and complication were evaluated.
Results
Technical success was achieved in 12 of 14 patients (85.7%) with 2 cases of incomplete embolization due to failed selection of ovarian artery (n=1) and high flow arteriovenous fistula (n=1). Clinical success rate for primary treatment of RPOC was 91.7% (11/12). Successful 11 cases didn't require additional treatment, but 1 patient who persisted mild vaginal bleeding after incomplete embolization underwent D&C. Two patients, who underwent pre-operative embolization, ceased vaginal bleeding after embolization, followed by D&C without bleeding complication. Bilateral UAE was performed in all patients, and extra-uterine feeder was found in 2 cases; ovarian artery and round ligament artery. All patients showed hypervascularity on angiography, and 13 of 14 patients showed dilated early draining vein. Pre-procedure color Doppler study showed echogenic mass with marked vascularity in all patients. Follow-up US (n=9) revealed decreased mass size (mean size; 4.6 cm to 2.3 cm, p < .01) and vascularity, there was no procedure related major complication.
Conclusions
UAE is safe and effective modality as a primary treatment of RPOC with marked vascularity.